Biocept, Inc. (BIOCQ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 16, 2025, 3:25 PM EDT
Biocept Revenue
Biocept had revenue of $589 thousand in the quarter ending June 30, 2023, a decrease of -89.88%. This brings the company's revenue in the last twelve months to $1.36 million, down -97.63% year-over-year. In the year 2022, Biocept had annual revenue of $25.86 million, down -57.78%.
Revenue (ttm)
1.36M
Revenue Growth
-97.63%
P/S Ratio
0.00
Revenue / Employee
27.14K
Employees
50
Market Cap
263.00
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 25.86M | -35.39M | -57.78% |
Dec 31, 2021 | 61.25M | 33.79M | 123.04% |
Dec 31, 2020 | 27.46M | 21.93M | 396.71% |
Dec 31, 2019 | 5.53M | 2.28M | 70.09% |
Dec 31, 2018 | 3.25M | -1.82M | -35.87% |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2013 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |